$FEMY
FEMASYS INC

2022 Q4 Form 10-Q Financial Statement

#000114036122040812 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $234.2K $347.5K $269.6K
YoY Change -7.9% 28.89%
Cost Of Revenue $85.46K $131.5K $105.4K
YoY Change 32.89% 24.72%
Gross Profit $148.8K $216.0K $164.2K
YoY Change -21.7% 31.57%
Gross Profit Margin 63.52% 62.17% 60.9%
Selling, General & Admin $1.743M $1.485M $1.131M
YoY Change 28.9% 31.38%
% of Gross Profit 1171.39% 687.69% 688.66%
Research & Development $1.272M $1.648M $1.141M
YoY Change 20.66% 44.5%
% of Gross Profit 854.69% 763.02% 694.71%
Depreciation & Amortization $134.7K $139.6K $144.4K
YoY Change -5.01% -3.32%
% of Gross Profit 90.57% 64.63% 87.95%
Operating Expenses $3.149M $3.273M $2.416M
YoY Change 23.61% 35.5%
Operating Profit -$3.000M -$3.057M -$2.251M
YoY Change 27.26% 35.79%
Interest Expense $114.8K $6.005K -$5.410K
YoY Change -4098.26% -211.0%
% of Operating Profit
Other Income/Expense, Net -$2.280K $74.35K -$2.850K
YoY Change 812.0% -2708.63%
Pretax Income -$2.888M -$2.983M -$2.260M
YoY Change 22.32% 32.0%
Income Tax $6.300K $0.00
% Of Pretax Income
Net Earnings -$2.894M -$2.983M -$2.260M
YoY Change 22.38% 32.0%
Net Earnings / Revenue -1235.57% -858.48% -838.23%
Basic Earnings Per Share -$0.25 -$0.19
Diluted Earnings Per Share -$0.24 -$0.25 -$0.19
COMMON SHARES
Basic Shares Outstanding 11.81M 11.81M 11.80M
Diluted Shares Outstanding 11.81M 11.80M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.96M $16.01M $27.28M
YoY Change -47.7% -41.33%
Cash & Equivalents $12.96M $16.01M $27.28M
Short-Term Investments
Other Short-Term Assets $655.4K $760.6K $759.5K
YoY Change 17.9% 0.15%
Inventory $436.7K $343.1K $150.3K
Prepaid Expenses
Receivables $77.47K $183.1K $143.5K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.13M $17.29M $28.33M
YoY Change -44.87% -38.97%
LONG-TERM ASSETS
Property, Plant & Equipment $1.483M $1.542M $2.369M
YoY Change -7.25% -34.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $958.2K $789.6K $428.9K
YoY Change 46.19% 84.09%
Total Long-Term Assets $2.764M $2.740M $2.831M
YoY Change -6.15% -3.23%
TOTAL ASSETS
Total Short-Term Assets $14.13M $17.29M $28.33M
Total Long-Term Assets $2.764M $2.740M $2.831M
Total Assets $16.90M $20.03M $31.16M
YoY Change -40.88% -35.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $510.8K $419.1K $436.9K
YoY Change 14.64% -4.07%
Accrued Expenses $456.7K $649.6K $597.9K
YoY Change -24.36% 8.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $515.1K $666.7K $733.8K
YoY Change -12.36% -9.14%
Total Short-Term Liabilities $1.528M $1.808M $1.820M
YoY Change -9.71% -0.7%
LONG-TERM LIABILITIES
Long-Term Debt $28.58K $115.8K $501.9K
YoY Change -92.9% -76.93%
Other Long-Term Liabilities $96.66K $101.8K $188.9K
YoY Change -46.1%
Total Long-Term Liabilities $125.2K $217.6K $690.8K
YoY Change -77.32% -68.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.528M $1.808M $1.820M
Total Long-Term Liabilities $125.2K $217.6K $690.8K
Total Liabilities $1.653M $2.025M $2.511M
YoY Change -26.34% -19.35%
SHAREHOLDERS EQUITY
Retained Earnings -$94.13M -$91.24M
YoY Change 13.77%
Common Stock $11.99K $11.93K
YoY Change 0.55%
Preferred Stock
YoY Change
Treasury Stock (at cost) $60.00K $60.00K
YoY Change 0.0%
Treasury Stock Shares $117.2K $117.2K
Shareholders Equity $15.24M $18.01M $28.65M
YoY Change
Total Liabilities & Shareholders Equity $16.90M $20.03M $31.16M
YoY Change -40.88% -35.72%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$2.894M -$2.983M -$2.260M
YoY Change 22.38% 32.0%
Depreciation, Depletion And Amortization $134.7K $139.6K $144.4K
YoY Change -5.01% -3.32%
Cash From Operating Activities -$2.868M -$2.730M -$1.801M
YoY Change 27.58% 51.55%
INVESTING ACTIVITIES
Capital Expenditures $93.88K -$18.54K -$175.7K
YoY Change -179.14% -89.45%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$93.88K -$18.54K -$175.7K
YoY Change -20.86% -89.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -81.95K -362.0K -601.3K
YoY Change -37.32% -39.79%
NET CHANGE
Cash From Operating Activities -2.868M -2.730M -1.801M
Cash From Investing Activities -93.88K -18.54K -175.7K
Cash From Financing Activities -81.95K -362.0K -601.3K
Net Change In Cash -3.044M -3.111M -2.579M
YoY Change 21.88% 20.64%
FREE CASH FLOW
Cash From Operating Activities -$2.868M -$2.730M -$1.801M
Capital Expenditures $93.88K -$18.54K -$175.7K
Free Cash Flow -$2.962M -$2.712M -$1.626M
YoY Change 39.1% 66.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
CY2021Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
821515
CY2022Q3 us-gaap Interest Expense
InterestExpense
6005
CY2021Q3 us-gaap Interest Expense
InterestExpense
7055
us-gaap Interest Expense
InterestExpense
9622
us-gaap Interest Expense
InterestExpense
14546
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
74346
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8256
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
99928
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
806076
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
20937928
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
51762
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2982843
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
18006847
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
26332382
femy Expiration Of Warrant
ExpirationOfWarrant
0
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16151
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
158288
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
30879705
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33388
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2259701
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
28653392
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-51815728
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
112145
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
30022357
femy Automatic Conversion Of Preferred Stock In Connection With Ipo
AutomaticConversionOfPreferredStockInConnectionWithIPO
55343686
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
163924
us-gaap Net Income Loss
NetIncomeLoss
-5172992
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
28653392
us-gaap Other Noncash Income
OtherNoncashIncome
0
us-gaap Other Noncash Income
OtherNoncashIncome
821515
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
3800
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
0
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
232845
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
1578643
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Femasys Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-3713499
dei Entity Address Address Line1
EntityAddressAddressLine1
3950 Johns Creek Court, Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Suwanee
dei City Area Code
CityAreaCode
770
dei Local Phone Number
LocalPhoneNumber
500-3910
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value
dei Trading Symbol
TradingSymbol
FEMY
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11813610
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
280577
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
36037
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
36037
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
45828
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-510730
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity File Number
EntityFileNumber
001-40492
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30024
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001339005
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
181123
CY2022Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
22
CY2021Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2850
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
22
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2850
us-gaap Net Income Loss
NetIncomeLoss
-8499974
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
18006847
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2850
femy Property And Equipment Costs Included In Accounts Payable
PropertyAndEquipmentCostsIncludedInAccountsPayable
23037
femy Property And Equipment Costs Included In Accounts Payable
PropertyAndEquipmentCostsIncludedInAccountsPayable
0
femy Prepaid Insurance Financed With Promissory Note
PrepaidInsuranceFinancedWithPromissoryNote
280577
femy Prepaid Insurance Financed With Promissory Note
PrepaidInsuranceFinancedWithPromissoryNote
320866
femy Conversion Of Convertible Preferred Stock To Common Stock
ConversionOfConvertiblePreferredStockToCommonStock
0
femy Conversion Of Convertible Preferred Stock To Common Stock
ConversionOfConvertiblePreferredStockToCommonStock
55360897
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
CY2022Q3 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
CY2021Q3 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
femy Percentage Of Restocking Fee
PercentageOfRestockingFee
0.30
us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
51762
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33388
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
158288
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
163924
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1079749
femy Share Based Compensation Expense To Be Recognized Upon Achieving Certain Performance Condition
ShareBasedCompensationExpenseToBeRecognizedUponAchievingCertainPerformanceCondition
463311
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
616438
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2982843
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2982843
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2259701
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2259701
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8499974
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8499974
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5172992
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5172992
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11813610
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11813610
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11799720
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11799720
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11810289
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11810289
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4996680
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4996680
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.04
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1071573
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
696163
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1071573
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
696163
CY2022Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
233460
CY2021Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
244572
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
233460
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
244572
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1305033
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
940735
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1305033
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
940735

Files In Submission

Name View Source Status
0001140361-22-040812-index-headers.html Edgar Link pending
0001140361-22-040812-index.html Edgar Link pending
0001140361-22-040812.txt Edgar Link pending
0001140361-22-040812-xbrl.zip Edgar Link pending
brhc10043761_10q.htm Edgar Link pending
brhc10043761_ex31-1.htm Edgar Link pending
brhc10043761_ex31-2.htm Edgar Link pending
brhc10043761_ex32-1.htm Edgar Link pending
brhc10043761_ex32-2.htm Edgar Link pending
femy-20220930.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
femy-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brhc10043761_10q_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
femy-20220930_def.xml Edgar Link unprocessable
femy-20220930_lab.xml Edgar Link unprocessable
femy-20220930_pre.xml Edgar Link unprocessable